RecruitingNCT07179510

Evaluation of the Safety and Performance of the Neocement® Inject P: A Prospective Observational Study in Dental Area


Sponsor

Bioceramed

Enrollment

66 participants

Start Date

Oct 6, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to collect real-world clinical data to gather information on the performance and safety of the Neocement® Inject P when used according to its intended purpose and current clinical applications. The results of the clinical study will serve as clinical evidence for the device's clinical evaluation.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adult males or females (age \> 18 years old);
  • Patients who are able to sign an informed consent form (for data collection);
  • Patients undergoing reconstructive dental surgery and indicated for the use of Neocement® Inject P;

Exclusion Criteria9

  • Patients who are unable to understand consent and the objectives of the study;
  • Signs of local or systemic acute/ active or chronic infections;
  • Metabolic affections;
  • Severe degenerative diseases, conditions in which general bone grafting is not advisable;
  • Implementation sites that allow product migration;
  • Conditions which require structural support in the skeletal system;
  • Conditions where the implantation site is unstable and not rigidly fixated;
  • Sensibility to the implantable materials;
  • Known hypersensitivity to the implant material.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Egas Moniz School of Health and Science

Lisbon, Portugal

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07179510


Related Trials